Unicycive Therapeutics SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KSept. 29, 2026, 7:46 a.m. ETView on SEC.gov
Departure/appointment of directors or officers · Other events · Financial statements and exhibits
8-KSept. 28, 2026, 4:31 p.m. ETView on SEC.gov
Other events
SCHEDULE 13G/AAug. 14, 2026, 4:15 p.m. ETView on SEC.gov
SCHEDULE 13G/AAug. 14, 2026, 4:37 p.m. ETView on SEC.gov
8-KAug. 12, 2026, 8:04 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
10-QAug. 12, 2026, 6:30 a.m. ETView on SEC.gov
SCHEDULE 13GJuly 30, 2026, 11:18 a.m. ETView on SEC.gov
4/AJuly 28, 2026, 4:15 p.m. ETView on SEC.gov
4/AJuly 28, 2026, 4:15 p.m. ETView on SEC.gov